Valens director reports option and share holdings

Valens Semiconductor Ltd. director Peter Mertens filed a Form 3, providing an initial statement of his holdings in the company.

Accepted by SEC EDGAR 03/18/2026 - 01:48 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Valens Semiconductor Ltd. director Peter Mertens filed a Form 3, providing an initial statement of his holdings in the company. The filing lists multiple stock options to acquire ordinary shares at exercise prices ranging from $0.86 to $7.58, with expirations between 2029 and 2033. Some options are fully vested and immediately exercisable, while others vest 25% on December 16, 2026 and the remaining 75% in twelve equal quarterly installments thereafter, subject to continued service. The filing also discloses direct holdings of ordinary shares, and notes that certain shares were issued upon vesting of previously granted RSUs. It does not report any new buy or sell transactions.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Mertens Peter

Role Director

Type	Security	Shares	Price	Value
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Ordinary Shares	--	--	--
Holding	Ordinary Shares	--	--	--

Holdings: Stock Option (Right to Buy) — 1,586,621 contracts (Direct); Ordinary Shares — 144,906 shares (Direct)

Footnotes (7)

F1. These shares were issued upon vesting of previously granted RSU's
F2. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units in four Equal portions on a quarterly basis within 90 days, 180 days, 270 days of the first anniversary of the date of grant (01/15/2026) , subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F3. The Stock Options are Fully vested and immediately exercisable
F4. The Options vest 25% on the first Vesting Date (12/16/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F5. The Options vest 25% on the first Vesting Date (12/16/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F6. The Options vest 25% on the first Vesting Date (12/16/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F7. The Options vest in four Equal portions on a quarterly basis within 90 days, 180 days, 270 days of the first anniversary of the date of grant (01/15/2026), subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Valens Semiconductor (VLN) Form 3 for Peter Mertens disclose?

The Form 3 discloses director Peter Mertens’ existing holdings in Valens Semiconductor, including stock options and ordinary shares. It details exercise prices, expiration dates, and vesting terms for the options, along with direct ownership of ordinary shares at the reporting date.

Does the Valens Semiconductor (VLN) Form 3 show any insider buying or selling?

The Form 3 does not show any insider buying or selling. It is an initial ownership report, listing existing stock option grants and ordinary share holdings, rather than recording new purchase or sale transactions in Valens Semiconductor securities.

What stock option positions are reported for Peter Mertens in Valens Semiconductor (VLN)?

The filing reports several stock option grants on Valens ordinary shares with exercise prices from $0.86 to $7.58 and expirations between 2029 and 2033. Some options are fully vested and exercisable, while others follow multi-year vesting schedules tied to continued service.

How do Peter Mertens’ Valens Semiconductor (VLN) options vest according to the Form 3?

Certain options vest 25% on an initial vesting date of December 16, 2026, with the remaining 75% vesting in twelve equal quarterly installments. Other equity awards, including RSUs, vest in quarterly portions after the first anniversary of a January 15, 2026 grant date.

What information about RSUs appears in the Valens Semiconductor (VLN) Form 3?

The Form 3 notes that some shares were issued upon vesting of previously granted RSUs. It explains that each RSU represents a contingent right to receive one ordinary share, with units vesting in four equal quarterly portions after the first anniversary of the January 15, 2026 grant date.

Are Peter Mertens’ Valens Semiconductor (VLN) holdings direct or indirect in this Form 3?

The holdings reported in the Form 3 are shown as direct ownership. Both the stock options on Valens ordinary shares and the ordinary share positions themselves are coded as directly owned by Peter Mertens, with no indirect ownership entities indicated in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mertens Peter

(Last)

(First)

(Middle)

ROEDELBERGWEG 14

(Street)

EPPSTEIN

(City)

(State)

(Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Valens Semiconductor Ltd. [ VLN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	97,059⁽¹⁾	D
Ordinary Shares	47,847⁽²⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	03/24/2021⁽³⁾	03/30/2030	Ordinary Shares	371,018	$0.86	D
Stock Option (Right to Buy)	04/15/2022⁽³⁾	01/15/2029	Ordinary Shares	14,230	$7.58	D
Stock Option (Right to Buy)	04/15/2023⁽³⁾	01/15/2030	Ordinary Shares	14,230	$4.99	D
Stock Option (Right to Buy)	04/14/2024⁽³⁾	01/15/2031	Ordinary Shares	44,650	$2.39	D
Stock Option (Right to Buy)	04/15/2025⁽³⁾	01/15/2032	Ordinary Shares	35,689	$2.41	D
Stock Option (Right to Buy)	12/16/2026⁽⁴⁾	12/16/2032	Ordinary Shares	350,000	$2	D
Stock Option (Right to Buy)	12/16/2026⁽⁵⁾	12/16/2032	Ordinary Shares	350,000	$3.25	D
Stock Option (Right to Buy)	12/16/2026⁽⁶⁾	12/16/2032	Ordinary Shares	350,000	$4.25	D
Stock Option (Right to Buy)	04/15/2026⁽⁷⁾	01/15/2033	Ordinary Shares	56,804	$1.66	D

Explanation of Responses:

1. These shares were issued upon vesting of previously granted RSU's

2. The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units in four Equal portions on a quarterly basis within 90 days, 180 days, 270 days of the first anniversary of the date of grant (01/15/2026) , subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

3. The Stock Options are Fully vested and immediately exercisable

4. The Options vest 25% on the first Vesting Date (12/16/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

5. The Options vest 25% on the first Vesting Date (12/16/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

6. The Options vest 25% on the first Vesting Date (12/16/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.

7. The Options vest in four Equal portions on a quarterly basis within 90 days, 180 days, 270 days of the first anniversary of the date of grant (01/15/2026), subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date.

Remarks:

This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

	Peter Mertens by: Oppenheimer Israel, as Attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR